| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.23 | 0.001 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |